Search
Legend Biotech Corp
LEGNAdd to Watchlist
18.450USD
-0.190-1.02%
Close 09-22 16:00（ET）
3.59BMarket Cap
LossP/E TTM
Legend Biotech Corp (LEGN) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to Legend Biotech Corp in the past month.
Buy
4 Strong Buy
8 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
50.457USD+170.69%
LEGN Analyst Recommendation Trends
In the current month, LEGN has received 8 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. LEGN average Analyst price target in the last month is 50.457.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
3
5
5
5
5
5
5
8
8
9
10
11
11
11
12
5
5
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
16
16
17
18
18
18
19
LEGN Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, LEGN EPS is projected to reach 0.014 in FY2026Q3, following reported EPS of 0.178 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.11
-0.02
0.07
0.01
0.04
Actual
-0.17
-0.29
0.18
--
--
Surprise
-53.63%
-1289.67%
+137.07%
--
--
FAQs
What is Legend Biotech Corp's expected revenue for the next quarter?
Legend Biotech Corp's expected revenue is 359.39M.
What is Legend Biotech Corp's price target?
Analysts forecast that Legend Biotech Corp's price target is USD 50.46, with the highest forecast at USD 74.00 and the lowest forecast at USD 24.00.
How have Legend Biotech CorpLEGN's recent earnings per share performed?
The market expectation was USD 0.18, while Legend Biotech CorpLEGN's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for Legend Biotech Corp?
Based on the ratings of Legend Biotech Corp's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.